openPR Logo
Press release

Selective Serotonin Reuptake Inhibitors Market Emerging Trend, Industry Demand, Business Review by 2031

11-13-2024 03:22 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Selective Serotonin Reuptake Inhibitors Market

Selective Serotonin Reuptake Inhibitors Market

The global selective serotonin reuptake inhibitors (SSRI) market is expected to grow at a significant CAGR during the forecast period (2024-2031). The prevalence of depression is on the rise throughout the globe. Depression and serotonin levels are linked as depression is indicated by a decrease in serotonin levels. As a result, pharmaceutical companies have developed SSRIs that block 5-hydroxytryptamine (5-HT) reuptake transporters to raise serotonin levels in the synaptic cleft. In addition, SSRIs are better absorbed in the gastrointestinal tract than other antidepressants. During the forecast period, the market is expected to increase significantly.

Get Free Sample link @ https://www.omrglobal.com/request-sample/selective-serotonin-reuptake-inhibitors-market

One of the main factors fueling SSRI medicine sales is the increased prevalence of mental diseases. There is a growing demand for effective neurological medications as the number of mental diseases rises. Mental illness has risen to become one of the most commonly diagnosed conditions on the planet. As the frequency of mental illness rises, so does the number of individuals in need of efficient neurological treatment. Owing to the improved therapeutic efficacy of selective serotonin reuptake inhibitors, mentally ill patients are more inclined to choose SSRIs for antidepressant medications. As a result of the rising prevalence of mental diseases, the global SSRI market is likely to develop throughout the forecast period. SSRIs have a high therapeutic efficacy among the many neurological medications available on the market. The number of companies producing these medications is growing. Furthermore, with government help, health insurance companies have begun to pay treatment costs for mental disorders.

Additionally, the market is expected to grow owing to the growing geriatric population. Mental illnesses are common among those who have concomitant ailments like heart disease or cancer. The above-mentioned health issues affect the bulk of the older population. When compared to the adult population, the geriatric population has the highest chance of having mental problems. The market is expected to develop due to rising awareness of depression among the older population and healthcare professionals, as well as the increasing availability of SSRI treatment regimens for such patients.

Full report of Selective Serotonin Reuptake Inhibitors Market available @ https://www.omrglobal.com/industry-reports/selective-serotonin-reuptake-inhibitors-market

Market Coverage

Segment Covered
Regions Covered- Globally

Competitive Landscape: GlaxoSmithKline (GSK), Merck & Co., Aurobindo Pharma Ltd., Takeda Pharmaceutical Co. Ltd., among others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominates the market in base year?
Which segment and region will project fastest growth in the market?
How COVID-19 impacted the market?
o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Selective Serotonin Reuptake Inhibitors Market by Segment

By Application

Depression
Anxiety and Panic Disorder
Other

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/selective-serotonin-reuptake-inhibitors-market

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Selective Serotonin Reuptake Inhibitors Market Emerging Trend, Industry Demand, Business Review by 2031 here

News-ID: 3733714 • Views:

More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by

All 5 Releases


More Releases for SSRI

Selective Serotonin Reuptake Inhibitors Market Comprehensive Insight by Growth R …
Selective Serotonin Reuptake Inhibitors Market is expected to grow at a significant CAGR during the forecast period. The prevalence of depression is on the rise throughout the globe. Depression and serotonin levels are linked as depression is indicated by a decrease in serotonin levels. As a result, pharmaceutical companies have developed SSRIs that block 5-hydroxytryptamine (5-HT) reuptake transporters to raise serotonin levels in the synaptic cleft. In addition, SSRIs are
Selective Serotonin Reuptake Inhibitors Market: Analysis Report, Share, Trends a …
The global selective serotonin reuptake inhibitors (SSRI) market is expected to grow at a significant CAGR during the forecast period (2021-2027). The prevalence of depression is on the rise throughout the globe. Depression and serotonin levels are linked as depression is indicated by a decrease in serotonin levels. As a result, pharmaceutical companies have developed SSRIs that block 5-hydroxytryptamine (5-HT) reuptake transporters to raise serotonin levels in the synaptic cleft.
SSRI Market 2026|Major Manufacturers-Pfizer, Eli Lilly, Merck, Alexion, Allergan …
Global SSRI Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Increasing incidences of allergic conditions that trigger the hyper production of histamine will propel the market growth in the forecast period. However, increased preference for complementary and alternative medicine (CAM) may restrain the market growth. For Sample Copy
Antidepressant Drugs Market : Exploration on Eminent Players | Allergan, Alkerme …
Antidepressant Drugs Market size is projected to experience significant growth from 2018 to 2024. Increasing stress levels, depression, elevated alcoholism and crime rates in the younger populations are foremost driving factors for increased use of antidepressant drugs. Tremendous diagnosis of cancer and tumor patients that increases the incidence of depression among cancer patients will potentially grow antidepressants market. Request In-depth table of contents @ https://www.gminsights.com/request-toc/upcoming/2505 Growing geriatric population drives
Antidepressant Drugs Market : Study on Key Players | Allergan, Alkermes, AstraZe …
Antidepressant Drugs Market size is projected to experience significant growth from 2018 to 2024. Increasing stress levels, depression, elevated alcoholism and crime rates in the younger populations are foremost driving factors for increased use of antidepressant drugs. Tremendous diagnosis of cancer and tumor patients that increases the incidence of depression among cancer patients will potentially grow antidepressants market. Growing geriatric population drives anti-depressants market. Elderly population is prone
Antidepressant Drugs Market Trends: Key Players are Bristol Myers,GlaxoSmithKlin …
Antidepressant Drugs Market size is projected to experience significant growth from 2018 to 2024. Increasing stress levels, depression, elevated alcoholism and crime rates in the younger populations are foremost driving factors for increased use of antidepressant drugs. Tremendous diagnosis of cancer and tumor patients that increases the incidence of depression among cancer patients will potentially grow antidepressants market. Request for a Table of Contents of this research report - https://www.gminsights.com/request-toc/upcoming/2505 Growing